Markets.com Logo

CKDXF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.443$
  • Previous Close
    0.443$
  • 52 Week Change
    0.28$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.29$ - 0.57$
  • Dividend Per Share
    --
  • Market cap
    810 M$
  • EPS
    --
  • Beta
    1.494
  • Volume
    --

About

CKDXF.US refers to Compass Minerals International Inc. It's a stock that trades on the OTC (Over-the-Counter) market and represents shares in Compass Minerals International, a company that produces and markets salt, plant nutrition, and specialty minerals.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Company Performance: CKDXF.US's stock price hinges on Canakinumab data in cardiovascular risk reduction and cancer. Positive trial results often drive prices up, while failures can cause declines.

Market Sentiment: Overall investor confidence and risk appetite significantly influence CKDXF.US. Bullish market conditions can boost demand, while bearish sentiment may lead to sell-offs.

Regulatory Approval: Regulatory decisions regarding potential Canakinumab approvals impact the stock. FDA or EMA approval often triggers price increases due to potential revenue streams.

Competition: Competitor activities in related therapeutic areas affect investor perception of Canakinumab's market potential, influencing CKDXF.US's value. Novel treatments could negatively affect stock price.

Economic Conditions: Broad economic trends, like interest rates and inflation, influence investor decisions, impacting CKDXF.US. Economic recessions might reduce investments in pharmaceutical stocks.

Industry Trends: Developments in pharmaceuticals and biotechnology affect investor attitudes towards CKDXF.US. Positive industry innovation could boost stock price, whereas negative events could negatively affect it.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--